A vial of lyophilized peptide is filled to a target mass, and that mass goes on the label. What the number is a mass of is the question this page is about. The solid in the vial is not pure peptide: it is peptide plus the counterions it was isolated with, plus whatever water the solid holds. Both contribute real weight, and neither is a rounding error. If you take the label mass, add a measured volume of solvent, and divide, you get a concentration that is systematically too high — always in the same direction, never random.

How much too high depends on the sequence, the salt form and the drying — small enough to ignore for a range-finding experiment, large enough to matter for anything quantitative. What follows is where the extra mass comes from, what it does to a stock, what the reference methods actually measure, and which parts of this are measured rather than assumed.

Peptide content, and the two conventions a label can follow

Peptide content is the fraction of the solid's mass that is peptide. The remainder is counterion, water and any residual solvent or excipient. A label mass can be quoted on either of two bases, and the two are different numbers:

  • Gross mass. The weighed mass of everything in the vial. This is what a fill operation controls directly, because it is what a balance reads.
  • Net peptide mass. The mass of peptide alone, back-calculated by dividing the intended peptide mass by the measured peptide content and filling to that larger gross mass.

Neither convention is wrong; a label that states neither is the problem. A vial marked "10 mg" with no peptide content figure is ambiguous, and the ambiguity is worth whatever the counterion and water fractions of that lot amount to, which the worked example below puts at more than twenty percent for one plausible set of assumptions. Where a lot certificate reports peptide content it resolves that; where it does not, you are working on the gross-mass assumption whether or not you intended to.

Where the extra mass comes from

Counterions

Basic residues at neutral or acidic pH are protonated, that charge has to be balanced, and so the isolated solid is a salt. Which salt is usually decided by the process rather than by choice: solid-phase peptide synthesis relies on trifluoroacetic acid both as the cleavage agent and as the ion-pairing reagent in reversed-phase purification, so peptides from that route are obtained as TFA salts [1]. Acetate is the other counterion commonly seen, generally the result of a deliberate exchange step.

Water

A freeze-dried cake is hygroscopic and not anhydrous. Residual moisture in a freeze-dried protein cake can run to percent levels rather than a trace: one study of a lyophilized humanized monoclonal antibody formulation worked across vials with residual moistures from 1 to 8%, with the glass transition temperature falling from 80 °C at 1% moisture to 25 °C at 8% [2]. That was a sucrose-containing antibody formulation, not a peptide salt, so the numbers do not transfer — the order of magnitude is the point. Water present at those levels is weighed along with the peptide.

Trifluoroacetate, and why it does not simply wash out

Trifluoroacetate is the heaviest of the counterions commonly seen on synthetic peptides, and it is not easily removed. It is also tightly bound: the conventional removal procedure has been repeated freeze-drying with an excess of an acid stronger than TFA, generally HCl, which means working at very low pH and risking peptide degradation [3]. In a comparison on a dicationic octapeptide, reversed-phase HPLC and ion-exchange resin each achieved partial to almost complete exchange of trifluoroacetate for a weaker acid's anion such as acetate, while only a deprotonation/reprotonation cycle of the amino groups removed it completely; the authors gave pKa values of approximately 0 for TFA, −7 for HCl and 4.5 for acetic acid, and monitored exchange by 19F-NMR, 1H-NMR and ATR FT-IR [3].

A more recent study exchanged TFA for chloride by freeze-drying in HCl, validated FT-IR, 19F-NMR and HPLC with evaporative light-scattering detection for counterion quantification according to ICH guidelines, and reported 10 mM HCl as optimal, with no impact on peptide purity at any HCl concentration tested [1]. Those authors used the measured counterion contents to interpret how sequence differences, particularly positive charges, relate to the amount and possible localization of counterions, and concluded that counterion quantification and specification matter in assays using synthetic peptides [1].

The practical reading of both papers is that counterion content is a property of a specific lot and a specific process, not a constant you can look up for a sequence.

The arithmetic, worked

How heavy is a counterion

Trifluoroacetic acid is C2HF3O2. Using standard atomic weights: 2 × 12.011 + 1.008 + 3 × 18.998 + 2 × 15.999 = 24.022 + 1.008 + 56.994 + 31.998 = 114.02 g/mol. Acetic acid is C2H4O2: 2 × 12.011 + 4 × 1.008 + 2 × 15.999 = 24.022 + 4.032 + 31.998 = 60.05 g/mol. Per counterion that is a mass ratio of 114.02 ÷ 60.05 = 1.90. The acid masses are the right ones to carry into a salt formula weight, because forming the salt moves the acid's proton onto the peptide, so the full mass of the acid ends up in the solid. A peptide converted from the TFA salt to the acetate salt loses mass without losing any peptide, which is one reason two vials of the same compound can differ in peptide per milligram while both certificates read 99% pure.

A worked example

Take an idealized case, with the assumptions stated. Suppose a peptide of molecular weight 1,500 g/mol carries three basic sites, all protonated, each balanced by one counterion, and the solid contains no water. As the TFA salt:

  • Salt formula weight = 1,500 + 3 × 114.02 = 1,842.06 g/mol.
  • Peptide content = 1,500 ÷ 1,842.06 = 0.814, or 81.4% by weight.

As the acetate salt of the same peptide:

  • Salt formula weight = 1,500 + 3 × 60.05 = 1,680.15 g/mol.
  • Peptide content = 1,500 ÷ 1,680.15 = 0.893, or 89.3% by weight.

Now add water. If a certificate for that TFA-salt lot reports 5% water by mass, the peptide fraction of the whole solid is 0.814 × 0.95 = 0.773, or 77.3%. Counterion and water are multiplicative, not additive, because the water fraction applies to the salt as weighed.

Note what the idealization hides: whether every basic site actually carries a counterion, and only one, is exactly the quantity the counterion-analysis papers set out to measure: one study found peptides carrying trifluoroacetate in excess of the number expected from their positive charges before exchange, with the count settling at or slightly below the expected stoichiometric value after repeated exchange cycles, and concluded that counterion amount corresponds closely to the number of positively charged residues [1]. The calculation shows the size of the correction; it is not a substitute for a measured value.

What it does to a stock

The nominal calculation is the familiar one: 2 mL of solvent into a 10 mg vial gives 5 mg/mL. Applying 77.3% peptide content to that same vial:

  • Net peptide in the vial = 10 mg × 0.773 = 7.73 mg.
  • Corrected concentration = 7.73 mg ÷ 2 mL = 3.87 mg/mL.
  • Nominal molarity = 5 g/L ÷ 1,500 g/mol = 3.33 mmol/L.
  • Corrected molarity = 3.87 g/L ÷ 1,500 g/mol = 2.58 mmol/L.

The uncorrected figure is 3.33 ÷ 2.58 = 1.29, so 29% higher than the corrected one; put the other way, the true concentration is 1 − 0.773 = 22.7% below what the label arithmetic implies (running the same subtraction on the rounded molarities, (3.33 − 2.58) ÷ 3.33, gives 22.5%, the difference being rounding). That error propagates unchanged through every dilution made from the stock, and it does not average out across replicates, because every replicate inherits the same stock.

Purity is not content

An HPLC purity figure is normally a peak-area percentage: of the material the method detects and resolves, what proportion is the intended peptide. Counterions and water do not appear in that ratio. A solid can therefore be 99% pure and appreciably less than 99% peptide by weight at once, with no contradiction. Purity describes the composition of the peptide fraction; content describes how much of the vial that fraction is.

Reference-standard work separates the two. The published approach uses a two-step value assignment: a mass balance approach assigns a quantitative value to a bulk peptide material, which is then used as a standard to assign a final value to the vialed material, with identity and content-uniformity testing alongside [4]. Mass balance forces the accounting to close: peptide, impurities, water and counterion have to add up to what the balance read.

Amino acid analysis as the reference method

Amino acid analysis answers "how much peptide is in this solid" independently of what it was weighed with. The sample is hydrolyzed to free amino acids, which are separated and quantified against calibrated standards, and peptide mass is back-calculated from the residues recovered. Because it counts residues rather than weighing solid, it is blind to counterion and water by construction.

Its standing as a reference method was established on proteins rather than short peptides. An evaluation against Kjeldahl nitrogen assay and UV measurement found it reliable for quantitating small-to-medium proteins in the 6–22 kDa range, in good agreement with Kjeldahl when the calculation used more than one stable residue, and noted that for larger proteins such as 150 kDa immunoglobulins it may underestimate total protein [5]. Research peptides sit well below that validated range — a reason to expect the method to work, not a demonstration that it does.

The method's weak point is hydrolysis. There is no single hydrolysis condition with sufficient recovery of all amino acids, and unstable derivatives, incomplete reactions and inadequate chromatographic separation have all been identified as obstacles to precise quantitation by amino acid analysis [6]. Work in this area has moved toward chromatographic separation of all proteinogenic amino acids followed by tandem mass spectrometry with isotopically labeled internal standards, which addresses the detection side [6]. For a reader of a certificate the consequence is that an amino acid analysis result depends on the hydrolysis protocol and on which residues entered the calculation, and neither is usually stated.

How the methods compare when several labs run them

A multi-laboratory collaborative study on the nonapeptide oxytocin compared three approaches — HPLC assay, quantitative NMR and amino acid analysis — for inter-laboratory variability. The HPLC assay using the same peptide bulk material as the standard showed the lowest inter-lab coefficient of variation, though that figure excluded the uncertainty in the standard's own purity assignment, which had been made by mass balance. The authors described qNMR as a direct measurement against an internal standard, not difficult to perform under common laboratory conditions, and concluded that its simpler operation and shorter analytical time make it worth further exploration as a primary method for value assignment [7].

Read that result precisely: the lowest-variability method was the one calibrated against a standard whose own uncertainty was set aside, so the ranking is about reproducibility between labs, not about which method is closest to the truth.

Cheaper orthogonal checks

Ultraviolet absorbance gives an independent read on concentration if the sequence has the right residues. Absorbance at 280 nm depends on tryptophan, tyrosine and cystine, and for a folded protein in water the molar absorption coefficient can be predicted as ε(280) = (#Trp)(5,500) + (#Tyr)(1,490) + (#cystine)(125) per M per cm; those predictions are reliable for proteins containing tryptophan and less reliable for those without, and the authors concluded that measuring ε is better than predicting it [8]. Many research peptides contain neither tryptophan nor tyrosine, which makes 280 nm useless for them; for that case a method exists for predicting molar absorptivity at 205 nm directly from sequence, which the authors report requires no calibration and should, they say, be suitable for a wide range of proteins and peptides [9].

A UV reading will not tell you the counterion fraction. It will tell you whether your gravimetric stock is roughly where you think it is, which is often the check actually needed.

The counterion is in the well too

Salt correction is not only bookkeeping: the counterion goes into the well with the peptide. Five antimicrobial peptides prepared as acetates, hydrochlorides and trifluoroacetates were compared in in-vitro antibacterial and cytotoxicity assays; the study found substantial differences between salts, but explicitly reported that the pattern was not consistent across the peptides [10]. The counterion-exchange study described above likewise found that permeability coefficients in a liposomal fluorescence assay differed depending on peptide sequence and salt form [1]. Neither result licenses a general rule about which salt performs better in a given assay — the honest summary is that salt form is a variable, and usually an unrecorded one.

Where residual TFA has to be measured in a solution rather than a solid, ion chromatography with suppressed conductivity detection has been validated for the purpose: a method for residual trifluoroacetic acid in a phosphate-buffered saline matrix reached 50 ng/mL, using a silver cartridge to selectively remove halide anions that would otherwise interfere [11].

What is measured and what is convention

Much of the above is arithmetic and analytical chemistry with primary literature behind it. Several of the habits surrounding it are convention with thin or no primary support, and the two are worth separating.

  • Measured. Counterion content, water content, purity and peptide content are all measurable quantities with established methods, and and they do not reproduce equally well: a multi-laboratory collaborative study quantified the inter-laboratory variability of an HPLC assay, quantitative NMR and amino acid analysis on one peptide, and they differed [7].
  • Convention. Reporting a stock concentration on the gross label mass is a convention, not a measurement. So is the widespread practice of treating purity as though it answered the content question.
  • Not known, per vial. For most research-grade material, peptide content is simply not reported. Where a certificate gives purity and identity but no content, water or counterion figures, the peptide fraction of that vial is unknown — not small, not negligible, unknown.

The correct response to an unknown is not to invent a correction factor. Assuming peptide content sits somewhere in the region implied by the counterion arithmetic ignores how wide that region is, and says nothing at all about the water. A defensible number has to be measured on the lot.

What to record

Whatever basis you work on, record it, so the concentration in a notebook can be reconstructed later. At minimum: the label mass and whether it is gross or net peptide; peptide content, water content and counterion identity where the certificate reports them; the volume of solvent added; whether the concentration you wrote down is nominal or corrected; and the lot, because every one of those figures is lot-specific.

A result generated on a nominal stock and one generated on a corrected stock are not the same experiment, and the difference is invisible in the data. It is visible only in the record.